Cargando…
Efficacy and safety of oral gemifloxacin for the empirical treatment of pneumonia
CONTEXT: Respiratory tract infections (RTI) are common causes of morbidity and mortality worldwide. Initial antibiotic therapy in upper and lower respiratory tract infections is usually empirical. The increasing evidence of antibacterial resistance in the pathogens commonly associated with pneumonia...
Autores principales: | Amitabh, Vindu, Singhal, Anish, Kumar, Sudhir, Patel, Narmada, Rizvi, Yasir S., Mishra, Pankaj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424864/ https://www.ncbi.nlm.nih.gov/pubmed/22919164 http://dx.doi.org/10.4103/0970-2113.99109 |
Ejemplares similares
-
Treatment of community-acquired pneumonia, with special emphasis on gemifloxacin
por: Öncü, Serkan
Publicado: (2007) -
Biphasic anaphylaxis to gemifloxacin
por: Yilmaz, İnsu, et al.
Publicado: (2012) -
Ion-pair spectrophotometric estimation of gemifloxacin
por: Sahu, Satyabrata, et al.
Publicado: (2012) -
Immunomodulatory activities of gemifloxacin in mice
por: Umair, Muhammad, et al.
Publicado: (2016) -
High efficacy of gemifloxacin-containing therapy in Helicobacter Pylori eradication: A pilot empirical second-line rescue therapy
por: Mahmoudi, Laleh, et al.
Publicado: (2016)